The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...
It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.
Mice with two fathers have been born—and have survived to adulthood—following a complex set of experiments by a team in China ...
Results prove that inversions can be generated in plants without causing further unwanted changes in the expression of genetic information.
Morgan Stanley lowered the firm’s price target on Crispr Therapeutics (CRSP) to $30 from $45 and keeps an Underweight rating on the shares. The ...
CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...
RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.
Researchers at Beijing's Chinese Academy of Sciences have used the gene-editing technology CRISPR to create mice from two ...
This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...
Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report), ...